FDA approves first RNA-based HCV (hepatitis C virus) tests
This article was originally published in Clinica
The FDA has approved the first qualitative RNA tests for sale in the US. Roche Diagnostics' Amplicor HCV Test, version 2.0, and Cobas Amplicor HCV Test, version 2.0 have gained market go-ahead for the direct detection of hepatitis C virus in patients who have evidence of liver disease and antibody evidence of HCV infection.
You may also be interested in...
South Korea’s Qurient achieves proof of concept in a Phase II study with its first-in-class antibiotic telacebec for tuberculosis and aims to file a US NDA for the orphan drug.
VMS businesses are deemed essential in Department of Homeland Security guidance that provides as basis for orders by most states and localities across the US. During an AHPA webinar, attorney Trent Norris says the federal government prefers leaving business exemptions to shut-down decisions to the states.
Company expects clinical trials to begin by September and says first batches could be available for emergency use authorization in early 2021; J&J pledges vaccine will be available to public on not-for-profit basis.